Yang Y Z, Little B, Meshnick S R
Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor 48109.
Biochem Pharmacol. 1994 Aug 3;48(3):569-73. doi: 10.1016/0006-2952(94)90287-9.
Artemisinin and its derivatives are a promising new class of antimalarial agents containing an endoperoxide bridge. [14C]Artemisinin alkylated various proteins in vitro. Between 5 and 18% of added drug bound to hemoproteins such as catalase, cytochrome c, and hemoglobin. However, it did not react with heme-free globin. For catalase and hemoglobin, most of the drug reacted with the protein moiety rather than the heme. Artemisinin bound to human serum albumin (HSA) more efficiently at pH 8.6 than 7.4, more efficiently in Dulbecco's PBS than in Tris-HCl buffer, and better when HSA had been made fatty acid-free. Dihydroartemisinin also bound to HSA, whereas deoxyartemisinin, an inactive derivative, did not. There was no binding between DNA and artemisinin. These data provide insight into the mechanism of the reaction between artemisinin and proteins.
青蒿素及其衍生物是一类很有前景的新型抗疟药物,含有一个内过氧化物桥。[14C]青蒿素在体外能使多种蛋白质烷基化。所添加药物的5%至18%与过氧化氢酶、细胞色素c和血红蛋白等血蛋白结合。然而,它不与无血红素的珠蛋白反应。对于过氧化氢酶和血红蛋白,大部分药物与蛋白质部分而非血红素反应。青蒿素在pH 8.6时比在pH 7.4时更有效地与人血清白蛋白(HSA)结合,在杜尔贝科磷酸盐缓冲盐溶液(Dulbecco's PBS)中比在Tris - HCl缓冲液中更有效地结合,并且当HSA去除脂肪酸后结合效果更好。双氢青蒿素也能与HSA结合,而无活性衍生物脱氧青蒿素则不能。DNA与青蒿素之间不存在结合。这些数据为深入了解青蒿素与蛋白质之间的反应机制提供了线索。